Literature DB >> 24509185

Comparison of four radiofrequency ablation systems at two target volumes in an ex vivo bovine liver model.

Hendrik Rathke1, Bernd Hamm, Felix Güttler, Joern Rathke, Jens Rump, Ulf Teichgräber, Maximilian de Bucourt.   

Abstract

PURPOSE: We aimed to validate actually achieved macroscopic ablation volumes in relation to calculated target volumes using four different radiofrequency ablation (RFA) systems operated with default settings and protocols for 3 cm and 5 cm target volumes in ex vivo bovine liver.
MATERIALS AND METHODS: Sixty-four cuboid liver specimens were ablated with four commercially available RFA systems (Radionics Cool-tip, AngioDynamic 1500X, Boston Scientific RF 3000, Celon CelonPower LAB): 16 specimens for each system; eight for 3 cm, and eight for 5 cm. Ablation diameters were measured, volumes were calculated, and RFA times were recorded.
RESULTS: For the 3 cm target ablation volume, all tested RFA systems exceeded the mathematically calculated volume of 14.14 cm3. For the 3 cm target ablation volume, mean ablation volume and mean ablation time for each RFA system were as follows: 28.5 ± 6.5 cm3, 12.0 ± 0.0 min for Radionics Cool-tip; 17.1 ± 4.9 cm3, 9.36 ± 0.63 min for AngioDynamic 1500X; 29.7 ± 11.7 cm3, 4.60 ± 0.50 min for Boston Scientific RF 3000; and 28.8 ± 7.0 cm3, 20.85 ± 0.86 min for Celon CelonPower LAB. For the 5 cm target ablation volume, Radionics Cool-tip (48.3 ± 9.9 cm3, 12.0 ± 0.0 min) and AngioDynamic 1500X (39.4 ± 16.2 cm3, 19.59 ± 1.13 min) did not reach the mathematically calculated target ablation volume (65.45 cm3), whereas Boston Scientific RF 3000 (71.8 ± 14.5 cm3, 9.15 ± 2.93 min) and Celon CelonPower LAB (93.9 ± 28.1 cm3, 40.21 ± 1.78 min) exceeded it.
CONCLUSION: While all systems reached the 3 cm target ablation volume, results were variable for the 5 cm target ablation volume. Only Boston Scientific RF 3000 and Celon CelonPower LAB created volumes above the target, whereas Radionics Cool-tip and AngioDynamic 1500X remained below the target volume. For the 3 cm target ablation volume, AngioDynamic 1500X with 21% deviation was closest to the target volume. For the 5 cm target volume Boston Scientific RF 3000 with 10% deviation was closest.

Entities:  

Mesh:

Year:  2014        PMID: 24509185      PMCID: PMC4463338          DOI: 10.5152/dir.2013.13157

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  18 in total

Review 1.  [Percutaneous radiofrequency ablation -- clinical indications and results].

Authors:  J Tacke
Journal:  Rofo       Date:  2003-02

Review 2.  [Percutaneous thermal ablation of renal neoplasms].

Authors:  J Tacke; A H Mahnken; R W Günther
Journal:  Rofo       Date:  2005-12

3.  Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results.

Authors:  A H Mahnken; D Rohde; D Brkovic; R W Günther; J A Tacke
Journal:  Acta Radiol       Date:  2005-04       Impact factor: 1.990

Review 4.  Tumor ablation with radio-frequency energy.

Authors:  G S Gazelle; S N Goldberg; L Solbiati; T Livraghi
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

5.  Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.

Authors:  Craig B Glaiberman; Thomas K Pilgram; Daniel B Brown
Journal:  J Vasc Interv Radiol       Date:  2005-10       Impact factor: 3.464

6.  Multipolar radiofrequency ablation of hepatic tumors: initial experience.

Authors:  Bernd B Frericks; Jörg P Ritz; Andre Roggan; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

7.  Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Spiros-G Delis; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

8.  MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages.

Authors:  J D Lee; J M Lee; S W Kim; C S Kim; W S Mun
Journal:  Korean J Radiol       Date:  2001 Jul-Sep       Impact factor: 3.500

9.  Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results.

Authors:  P Bruners; T Schmitz-Rode; R W Günther; A Mahnken
Journal:  Rofo       Date:  2008-03

10.  Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers.

Authors:  Philippe L Pereira; Jochen Trübenbach; Martin Schenk; Jörg Subke; Stephan Kroeber; Ines Schaefer; Christopher T Remy; Diethard Schmidt; Jens Brieger; Claus D Claussen
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

View more
  5 in total

1.  RF-ablation pattern shaping employing switching channels of dual bipolar needle electrodes: ex vivo results.

Authors:  Jens Ziegle; Chloé Audigier; Johannes Krug; Ghazanfar Ali; Younsu Kim; Emad M Boctor; Michael Friebe
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-04-20       Impact factor: 2.924

2.  Establishment of a Tissue-Mimicking Surrogate for Pulmonary Lesions to Improve the Development of RFA Instruments and Algorithms.

Authors:  Louisa Bühler; Markus D Enderle; Nicolas Kahn; Markus Polke; Marc A Schneider; Claus Peter Heußel; Felix J F Herth; Walter Linzenbold
Journal:  Biomedicines       Date:  2022-05-10

3.  Switching Monopolar No-Touch Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma: A Randomized Clinical Trial.

Authors:  Sae-Jin Park; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Jin Kang; Jeong Hee Yoon; Dong Ho Lee; Se Hyung Kim; Jae Young Lee; Jeong Min Lee
Journal:  Liver Cancer       Date:  2020-12-08       Impact factor: 11.740

4.  Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model.

Authors:  Krishna Pillai; Javid Akhter; Terence C Chua; Mena Shehata; Nayef Alzahrani; Issan Al-Alem; David L Morris
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

5.  Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study.

Authors:  Béatrice Bouhanick; Marie C Delchier; Séverine Lagarde; Romain Boulestreau; Claude Conil; Philippe Gosse; Hervé Rousseau; Benoit Lepage; Pascale Olivier; Panteleimon Papadopoulos; Hervé Trillaud; Antoine Cremer
Journal:  J Hypertens       Date:  2021-04-01       Impact factor: 4.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.